US President-elect Trump: Opposing Ukrainian armed forces to attack Russia with US long-range missiles has further escalated the conflict.Tiankang Bio: Tiankang Bio (002100) announced on the evening of December 12 that Tiankang Bio (stock code: 874339), a holding subsidiary of the company, intends to apply for public offering of shares to unspecified qualified investors and listing on the Beijing Stock Exchange. As of the disclosure date of the announcement, Tiankang Bio's public offering of shares to unspecified qualified investors and listing on the North Stock Exchange are under counseling.Australia's unemployment rate in November was 3.93%, which is estimated to be 4.2%.
Yibin Paper: Terminate the issue of A shares to specific targets in 2022 and withdraw the application documents. Yibin Paper announced that the company held the 31st meeting of the 11th Board of Directors and the 22nd meeting of the 11th Board of Supervisors on December 12, 2024, and deliberated and passed the Proposal on Terminating the Issue of A shares to specific targets in 2022 and withdrawing the application documents. Considering the changes in market environment and policies, and considering the actual situation, the company decided to terminate the issuance of A shares to specific targets.Xinwangda: The subsidiary and Xiamen Tungsten Xinneng signed the Framework Agreement on Strategic Cooperation for Solid-State Batteries. Xinwangda announced that the subsidiary Xinwangda Power and Xiamen Tungsten Xinneng signed the Framework Agreement on Strategic Cooperation for Solid-State Batteries, and the two sides will carry out extensive and in-depth cooperation on research and development, mass production and market development of a series of new energy battery materials for solid-state batteries around their respective development strategies. The cooperation contents include the development of cathode materials for solid-state batteries, the development of electrolytes and related materials for solid-state batteries, the cooperative development of solid-state batteries and industrial cooperation.The International Finance Corporation (IFC) and HSBC signed a $1 billion trade flow arrangement for emerging markets.
Li Tie's case will be pronounced in the first instance tomorrow. The court has informed his defender of the well-known football player Li Tie, the former head coach of China National Men's Football Team (hereinafter referred to as "China Men's Football Team"), that the case will be pronounced in public by the Intermediate People's Court of Xianning City, Hubei Province tomorrow, that is, December 13, 2024, Beijing time. In the previous court hearing, although Li Tie said that he "pleaded guilty and repented", he did not "plead guilty and admit punishment". (Economic Observer)Yuanda Environmental Protection: It is planned to invest in the flue gas treatment franchise project of 2× 1,000 MW units in Huainan Pingwei Power Plant Phase IV, reaching the environmental protection announcement. The franchise company, a wholly-owned subsidiary, plans to set up Pingwei Branch, build desulfurization, denitrification and dust removal facilities based on the 2× 1,000 MW units in Pingwei Power Plant Phase IV, and sign a franchise contract with Pingwei Power Plant to carry out the flue gas treatment franchise business. The static investment of the project is 641 million yuan, the dynamic investment is 662 million yuan, and the franchise period is not less than 20 years. It is estimated that the total annual profit of the project is 18.89 million yuan and the average annual net profit is 13.45 million yuan. This transaction will help Yuanda Environmental Protection to further expand its market in Anhui and surrounding areas, obtain long-term stable income and form new profit growth points.CITIC Securities: The resonance between supply and demand of medical beauty accelerates the space expansion, and the difference in operating ability promotes the evolution of the industry structure. CITIC Securities Research Report stated that the medical beauty industry has both medical and consumption attributes, and the medical attribute has strong product-driven characteristics, while the consumption attribute has high operating ability requirements. The medical beauty botulinum toxin track is also affected by the dual attributes of medicine and consumption: 1) The increase in penetration rate, the acceleration of compliance substitution and the extension of indications have brought about high demand for medical beauty botulinum toxin, and with the recent supply expansion, the industry scale has experienced high growth; 2) The iteration of product innovation is slow, brand barriers are created through marketing, doctors are empowered through direct sales, and control is strengthened to enhance product competitiveness. Recently, a variety of medical botulinum toxins in China have been approved, and the promotion of low-priced products is expected to push up the penetration rate, and enterprises with strong operational capabilities will enter the market or promote the evolution of the pattern.
Strategy guide
12-14
Strategy guide 12-14
Strategy guide
12-14
Strategy guide 12-14
Strategy guide 12-14